Company: RPID
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001380106-25-000200
Chunk: 257

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 1
Chunk 257
---
 increase in cash and cash equivalents and restricted cash$1,954 $(2,241)

Operating activities

During the nine months ended September 30, 2025, net cash used in operating activities was $27.8 million, a decrease of $6.4 million compared to the nine months ended September 30, 2024.  The lower use of net cash was primarily a result of lower personnel-related costs due to reduced headcount as well as the volume and timing of payments to vendors and increased customer cash receipts.  This decrease was partially offset by increased inventory purchases.

Investing activities

During the nine months ended September 30, 2025, net cash provided by investing activities was $10.4 million, a decrease of $21.4 million compared to the nine months ended September 30, 2024. Higher investment maturities in the prior-year period coupled with a decline in investment purchases contributed to the reduction in investing activities.  Additionally, cash expenditures for property and equipment were lower in the current-year period.

Financing activities

During the nine months ended September 30, 2025, net cash provided by financing activities was $19.3 million, an increase of $19.1 million compared to the nine months ended September 30, 2024. The primary driver of this increase was our issuance of long-term debt in August 2025. 

Seasonality

Our revenues vary from quarter to quarter as a result of factors such as our customers’ budgetary cycles and extended summer vacation periods that can impact our ability to progress system sales processes, deliver products and provide onsite services to our customers during those periods. We expect this variability to continue for the foreseeable future, which may cause fluctuations in our operating results and financial metrics.

Critical accounting estimates

Our condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses, and the disclosure of contingent assets and liabilities in our consolidated financial statements. Our estimates are based on our historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.

Our significant accounting policies are